Cellectis SA (CLLS)
NASDAQ:CLLS
Holding CLLS?
Track your performance easily

Cellectis SA (CLLS) Similar Stocks

864 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Crispr Therapeutics AG
$4.15B
-15.09
-1.93%
9 Buy
6 Hold
2 Sell
Moderate Buy
Editas Medicine
$319.18M
-1.64
-56.07%
6 Buy
6 Hold
0 Sell
Moderate Buy
Intellia Therapeutics
$2.40B
-4.31
-37.02%
17 Buy
4 Hold
0 Sell
Strong Buy
Bluebird Bio
$132.74M
-0.92
-80.67%
3 Buy
6 Hold
0 Sell
Moderate Buy
Cellectis SA
$166.45M
-2.13
25.40%
4 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
CRSP
Crispr Therapeutics AG
48.69
-0.96
-1.93%
EDIT
Editas Medicine
3.87
-4.94
-56.07%
NTLA
Intellia Therapeutics
23.63
-13.89
-37.02%
BLUE
Bluebird Bio
0.69
-2.87
-80.62%
CLLS
Cellectis SA
2.37
0.48
25.40%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis